Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19419207 | 0.86 | TSHR (0.43) | TSHR | |
| SCHEMBL21599306 | 0.80 | TSHR (0.50) | TSHR | |
| SCHEMBL19419162 | 0.77 | TSHR (0.43) | TSHR | |
| SCHEMBL19750115 | 0.76 | TSHR (0.46) | TSHR | |
| SCHEMBL19419070 | 0.75 | — | — | |
| SCHEMBL24792446 | 0.74 | TSHR (0.44) | TSHR | |
| SCHEMBL25283745 | 0.73 | TSHR (0.48) | TSHR | |
| SCHEMBL19419222 | 0.73 | TSHR (0.33) | TSHR | |
| SCHEMBL19419039 | 0.73 | — | — | |
| SCHEMBL10932800 | 0.73 | TSHR (0.67) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220416303-A1 | FUNCTIONALIZED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | ORBIA FLUOR & ENERGY MATERIALS USA, INC. | 2022-12-29 | — | — | US | disclosed |
| US-20220181674-A1 | NITRILE-SUBSTITUTED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | ORBIA FLUOR & ENERGY MATERIALS USA, INC. | 2022-06-09 | — | — | US | disclosed |
| US-20190326643-A1 | FUNCTIONALIZED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | ORBIA FLUOR & ENERGY MATERIALS USA, INC. | 2019-10-24 | — | — | US | disclosed |
| US-10355313-B2 | Functionalized silanes and electrolyte compositions and electrochemical devices containing them | SILATRONIX, INC. (US) | 2019-07-16 | — | — | US | disclosed |
| US-20180076477-A1 | NITRILE-SUBSTITUTED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | SILATRONIX INC (US) | 2018-03-15 | — | — | US | disclosed |
| US-20170301953-A1 | FUNCTIONALIZED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | ORBIA FLUOR & ENERGY MATERIALS USA, INC. | 2017-10-19 | — | — | US | disclosed |
| US-20170283443-A1 | FLUOROSILICON NITRILE COMPOUNDS | ARKEMA INC. | 2017-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180076477-A1 | NITRILE-SUBSTITUTED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | HCN4, HCN2, HCN3 | TSHR 3765/4885 |
| US-20170283443-A1 | FLUOROSILICON NITRILE COMPOUNDS | NCL, NOC2L, AFF4 | TSHR 2321/4885 |
| US-20190326643-A1 | FUNCTIONALIZED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | ZYX, HCN3, HCN4 | TSHR 2453/4885 |
| US-20170301953-A1 | FUNCTIONALIZED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | ZYX, HCN4, HCN3 | TSHR 1712/4885 |
| US-10355313-B2 | Functionalized silanes and electrolyte compositions and electrochemical devices containing them | ZYX, HCN4, HCN3 | TSHR 1921/4885 |
| US-20220181674-A1 | NITRILE-SUBSTITUTED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | HCN4, HCN2, HCN3 | TSHR 3765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.